Covered recipient · General Payments record
SHARON MCCLOSKEY
General Payments · PY2019–2025
$3,097.21
- Reported across 164 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $319.78 | 15 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $58.07 | 2 |
| MAYNE PHARMA COMMERCIAL LLC | $50.04 | 2 |
| Sumitomo Pharma America, Inc. | $47.99 | 2 |
| MILLICENT US INC | $36.36 | 2 |
| Exeltis, USA Inc. | $31.79 | 2 |
| Hologic Sales and Service, LLC | $24.40 | 1 |
| Organon LLC | $21.99 | 1 |
| ABBVIE INC. | $19.56 | 1 |
| PFIZER INC. | $14.98 | 1 |
| DEXCOM, INC. | $14.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (15)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.56 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203046260 | CMS |
| Biogen, Inc. | $28.96 | 02/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208466136 | CMS |
| Biogen, Inc. | $29.11 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208398046 | CMS |
| Dexcom, Inc. | $14.60 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250524844 | CMS |
| Exeltis, USA Inc. | $15.54 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218198965 | CMS |
| Exeltis, USA Inc. | $16.25 | 04/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218198967 | CMS |
| Hologic Sales and Service, LLC | $24.40 | 09/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1182522522 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $28.24 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254276675 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $21.80 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254277035 | CMS |
| MILLICENT US INC | $18.97 | 01/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235200285 | CMS |
| MILLICENT US INC | $17.39 | 05/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235200287 | CMS |
| Organon LLC | $21.99 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237638366 | CMS |
| PFIZER INC. | $14.98 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229029439 | CMS |
| Sumitomo Pharma America, Inc. | $25.48 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176689699 | CMS |
| Sumitomo Pharma America, Inc. | $22.51 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176689701 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.